Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04922268 · ClinicalTrials.gov registry record · NA
External Focus of Attention Posttraumatic Osteoarthritis
A NA study, sponsored by University of North Carolina, Charlotte.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT04922268: Completed NA study, sponsored by University of North Carolina, Charlotte.
NCT04922268 is a NA study that has completed, run by University of North Carolina, Charlotte. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04922268, a NA study, has completed, sponsored by University of North Carolina, Charlotte.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
Knee injuries, especially those to the ACL, are common among physically active people. These injuries are frequently treated with surgical reconstruction (ACL reconstruction; ACLR). While ACLR restores stability it does not protect against future injury, long-term pain, disability, and arthritis associated with these injuries. Our study is going to examine new ways to provide feedback about the way people move to determine if these are better at modifying movement patterns that are known risk factors of posttraumatic osteoarthritis development than current standard treatments. If you participate, you will be asked to undergo a movement analysis in a research laboratory while you perform tasks such as walking and hopping. After this initial assessment, you will be randomly allocated to one of 2 treatment groups. Each treatment group will perform 4 weeks (3x/week) of exercises to change the way people walk. Participants will then report for follow-up movement analysis testing 1- and 4-weeks after completing the intervention.
Primary Outcome
Knee and hip angles and loads measured via 3D biomechanics
Interventions
- OTHER Internal focus of attention feedback
- OTHER External focus of attention feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2024-08-31 |
| Phase | NA |
What the finished NCT04922268 record still lists
NCT04922268 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Internal focus of attention feedback is the first listed.
NCT04922268 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04922268 about?
NCT04922268 is a clinical study titled "External Focus of Attention Posttraumatic Osteoarthritis". Knee injuries, especially those to the ACL, are common among physically active people. These injuries are frequently treated with surgical reconstruction (ACL reconstruction; ACLR). While ACLR restores stability it does not protect against future injury, long-term pain, disability, and arthritis ass...
What is the current status of trial NCT04922268?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2022-01-01. Estimated completion is 2024-08-31.
What interventions are being tested in trial NCT04922268?
The interventions under investigation include: Internal focus of attention feedback (OTHER), External focus of attention feedback (OTHER).
Who is sponsoring clinical trial NCT04922268?
This trial is sponsored by University of North Carolina, Charlotte, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04922268's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI